Posted in | News | Business | Chemistry

AkzoNobel to Invest €140 Million in Frankfurt Chlorine Facility

AkzoNobel announced that it will invest €140 million to modify its chlorine facility in Frankfurt, Germany, to include an advanced membrane electrolysis technology.

With the new plant, AkzoNobel will expand its existing capacity by nearly 50% and enhance the overall eco-footprint for every ton of product by roughly 30%. The company will also strengthen its presence in the chloromethanes and caustic lye markets in Europe.

During the last quarter of 2013, the Frankfurt facility will start production with an expected capacity of 250 kilotons from its current capacity of 165 kilotons. AkzoNobel Industrial Chemicals runs two chlorine production facilities in Netherlands and three in Germany. These five plants produced over one million tons of chlorine in total in 2010. The company acquired the Frankfurt facility following its acquisition of LII Europe in 2009.

According to AkzoNobel’s executive committee member for specialty chemicals, Rob Frohn, the investment is in line with the company’s values and objectives. The Managing Director for AkzoNobel Industrial Chemicals, Knut Schwalenberg commented that switching to an advanced membrane technology perfectly fits with the company’s sustainability program and carbon policy. It will specifically support the company’s growing chloromethanes business, he added.



Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AkzoNobel. (2019, February 09). AkzoNobel to Invest €140 Million in Frankfurt Chlorine Facility. AZoM. Retrieved on May 24, 2024 from

  • MLA

    AkzoNobel. "AkzoNobel to Invest €140 Million in Frankfurt Chlorine Facility". AZoM. 24 May 2024. <>.

  • Chicago

    AkzoNobel. "AkzoNobel to Invest €140 Million in Frankfurt Chlorine Facility". AZoM. (accessed May 24, 2024).

  • Harvard

    AkzoNobel. 2019. AkzoNobel to Invest €140 Million in Frankfurt Chlorine Facility. AZoM, viewed 24 May 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.